Carcinoma: all 6,718 studies
Page 52 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- Sentinel Lymph Node (SLN) in Colorectal Carcinoma (CRC) With a Near-infrared (NIR)-DyeCompletedNCT02122523Not applicable
- Second Line Sorafenib After Pazopanib in Patients With RCCTerminatedNCT02122003Phase 2
- Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal CarcinomaCompletedNCT02120911Phase 1/2
- Topical Itraconazole in the Treatment of Basal Cell CarcinomaCompletedNCT02120677Early Phase 1
- Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell CarcinomaStatus unknownNCT02119559Not applicable
- Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal CancerCompletedNCT02118285Phase 1
- Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma PatientsCompletedNCT02114658Phase 2
- Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV PatientsCompletedNCT02113865
- Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II StudyCompletedNCT02113800Phase 2
- Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02111460Phase 3
- Alisertib in Chemotherapy-pretreated Urothelial CancerCompletedNCT02109328Phase 2
- Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular CarcinomaCompletedNCT02109146Phase 3
- Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian CarcinomaTerminatedNCT02107378Phase 2
- Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck CancerCompletedNCT02107235Phase 1
- A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary CancerWithdrawnNCT02105350Phase 1
- Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular CarcinomaTerminatedNCT02102022Phase 1/2
- Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver CancerCompletedNCT02101593Phase 1
- An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer ParticipantsCompletedNCT02100111
- The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02096380
- Aggressive Squamous Cell Carcinoma in Organ Transplant RecipientsCompletedNCT02095912
- CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract TumorsTerminatedNCT02094560Phase 2
- POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With TemsirolimusCompletedNCT02093598Phase 2
- TACE Study-Liver Embolization Perfusion (VGH Radiology LIU)CompletedNCT02093104
- Optimizing Pazopanib Exposure in RCC PatientsTerminatedNCT02089802Phase 2
- Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver CancerCompletedNCT02089763Phase 2
- Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCCCompletedNCT02089633Phase 2
- Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal CarcinomaStatus unknownNCT02089204
- Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell CarcinomaCompletedNCT02088515Phase 4
- LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian CarcinomaWithdrawnNCT02083536Phase 1
- HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data RegistryCompletedNCT02082886
- Continued Administration of G-202 for One Patient With Advanced Hepatocellular CarcinomaNo longer availableNCT02082691
- Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT)CompletedNCT02081131Not applicable
- To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular CarcinomaStatus unknownNCT02074202Phase 3
- Angiogenic Factor Expression During Fractionated IrradiationStatus unknownNCT02072720Early Phase 1
- Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT02072486Not applicable
- Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by SurgeryCompletedNCT02072356Early Phase 1
- Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs TherapyStatus unknownNCT02072044Phase 2
- Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC）Status unknownNCT02072031Phase 2
- Phase II Study of Sunitinib Rechallenge in Patients With Metastatic Renal Cell CarcinomaTerminatedNCT02071641Phase 2
- 3T MRI to Predict TACE Response of HCCStatus unknownNCT02070822
- TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver CancerWithdrawnNCT02070419Phase 2
- Circulating Tumor Cell Genome in Peripheral Blood From Hepatocellular Carcinoma Patients Under RadiotherapyStatus unknownNCT02066974
- Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CAStatus unknownNCT02064725Phase 2
- Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA AnalysisStatus unknownNCT02063399
- A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular CarcinomaCompletedNCT02061956
- Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and NeckCompletedNCT02061631Phase 2
- Safety, Tolerability and Performance of SmartMatrix Dermal Replacement ScaffoldTerminatedNCT02059252Phase 1/2
- OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive ChemoradiotherapyTerminatedNCT02058017Phase 1
- Image-guided Breast Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO)CompletedNCT02057432Not applicable
- SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHNCompletedNCT02057107Phase 2
- Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab TreatmentCompletedNCT02056587Phase 4
- Selection Criteria for Safe Hepatectomy for Hepatocellular CarcinomaCompletedNCT02056041
- F16IL2 Plus Paclitaxel in Metastatic Merkel Cell CarcinomaTerminatedNCT02054884Phase 2
- A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and NeckStatus unknownNCT02054442Phase 1/2
- Pretreatment MRI Predicting Outcome After Radio-frequency Ablation of HCCStatus unknownNCT02051283
- Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With ChemotherapyCompletedNCT02049047Phase 2
- Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor CellCompletedNCT02048540Phase 1/2
- Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx CancerCompletedNCT02048020Phase 2
- Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCCCompletedNCT02047201Phase 2
- Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency AblationStatus unknownNCT02046356
- Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)TerminatedNCT02045186Not applicable
- Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma PatientsStatus unknownNCT02044562Not applicable
- Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of EsophagusWithdrawnNCT02041819Phase 2
- Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial CarcinomaCompletedNCT02039388Not applicable
- Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma.Status unknownNCT02036216
- Interest of Narrow Band Imaging in Detection of Upper Aerodigestive CancersCompletedNCT02035735Not applicable
- A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell CarcinomaCompletedNCT02035657Phase 1
- Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02035527Phase 1
- Immunotherapy Study for Metastatic Renal Cell CancerCompletedNCT02035358Phase 1
- Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal CarcinomaWithdrawnNCT02034968Phase 2
- Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian CarcinomasStatus unknownNCT02033616Phase 2
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of EsophagusWithdrawnNCT02033538Phase 2
- Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal CancerCompletedNCT02032485Phase 2
- Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma RecurrenceCompletedNCT02032368Not applicable
- Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular CarcinomaCompletedNCT02031952Not applicable
- Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell CarcinomaCompletedNCT02030717Phase 2/3
- Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and CisplatinTerminatedNCT02029690Phase 1
- Topical Green Tea Ointment in Treatment of Superficial Skin CancerCompletedNCT02029352Phase 2/3
- RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)TerminatedNCT02026960Not applicable
- Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA).SuspendedNCT02026362Phase 1/2
- Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular CarcinomaCompletedNCT02025842
- Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer PatientsCompletedNCT02025062Not applicable
- Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous CancerStatus unknownNCT02025036Phase 3
- Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal CarcinomatosisCompletedNCT02024841Phase 1
- Protocole Advanced RadioTherapy ORLCompletedNCT02024035
- FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal CarcinomaCompletedNCT02023593Phase 2
- Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid StenosisSuspendedNCT02022293Phase 2
- Debio 1143-201 Dose-finding and Efficacy Phase I/II TrialCompletedNCT02022098Not applicable
- Influence of Probiotics Administration Before Liver Resection in Liver DiseaseCompletedNCT02021253Not applicable
- Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersCompletedNCT02020707Phase 1
- Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCCStatus unknownNCT02018757Phase 2
- Er:YAG Ablative Fractional Laser Assisted-Photodynamic Therapy Versus Photodynamic Therapy for Basal Cell CarcinomaCompletedNCT02018679Phase 1
- Does the Harmonic Scalpel Reduce Blood Loss and OR Time in Major Head and Neck Cancer Surgery Undergoing Major Surgery for Oral Cavity Squamous Cell Carcinoma?CompletedNCT02017834Not applicable
- Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer OriginWithdrawnNCT02017678Phase 2
- A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the EsophagusTerminatedNCT02017600Phase 2
- Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial CarcinomaCompletedNCT02017353Phase 2
- Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal CarcinomaStatus unknownNCT02016417Phase 2
- Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and NeckTerminatedNCT02015650Phase 4
- Natural History and Tissue Acquisition Study of Adrenocortical CarcinomaCompletedNCT02015026
- Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)WithdrawnNCT02014831Phase 2